2019 ESTRO-ACROP共识指南:影像学指导局限性前列腺癌的放射治疗

2019-10-23 欧洲放射肿瘤学学会 Radiother Oncol. 2019 Oct 23.

2019年10月,欧洲放射肿瘤学学会(ESTRO)发布了影像学指导局限性前列腺癌的放射治疗指南共识。影像学指导放射治疗的应用有助于解释前列腺癌放射治疗期间前列腺定位的变化,本文主要针对影像学指导局限性前列腺癌的放射治疗提供指导建议。

中文标题:

2019 ESTRO-ACROP共识指南:影像学指导局限性前列腺癌的放射治疗

英文标题:

ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer.

发布机构:

欧洲放射肿瘤学学会

发布日期:

2019-10-23

简要介绍:

2019年10月,欧洲放射肿瘤学学会(ESTRO)发布了影像学指导局限性前列腺癌的放射治疗指南共识。影像学指导放射治疗的应用有助于解释前列腺癌放射治疗期间前列腺定位的变化,本文主要针对影像学指导局限性前列腺癌的放射治疗提供指导建议。

 

拓展指南:前列腺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ESTRO-ACROP共识指南:影像学指导局限性前列腺癌的放射治疗)] GetToolGuiderByIdResponse(projectId=1, id=0fd8d1c0018235ca, title=2019 ESTRO-ACROP共识指南:影像学指导局限性前列腺癌的放射治疗, enTitle=ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer., guiderFrom=Radiother Oncol. 2019 Oct 23., authorId=null, author=, summary=2019年10月,欧洲放射肿瘤学学会(ESTRO)发布了影像学指导局限性前列腺癌的放射治疗指南共识。影像学指导放射治疗的应用有助于解释前列腺癌放射治疗期间前列腺定位的变化,本文主要针对影像学指导局限性前列腺癌的放射治疗提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=1624, associationName=欧洲放射肿瘤学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Oct 23 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年10月,欧洲放射肿瘤学学会(ESTRO)发布了影像学指导局限性前列腺癌的放射治疗指南共识。影像学指导放射治疗的应用有助于解释前列腺癌放射治疗期间前列腺定位的变化,本文主要针对影像学指导局限性前列腺癌的放射治疗提供指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>前列腺癌</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=daa061c001808aba" title="68Ga-前列腺特异性膜抗原PET/CT前列腺癌显像操作指南" target=_blank>68Ga-前列腺特异性膜抗原PET/CT前列腺癌显像操作指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6d9ec1c00180312d" title="2019 CUA/CUOG指南:去势抵抗性前列腺癌的管理" target=_blank>2019 CUA/CUOG指南:去势抵抗性前列腺癌的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=540841c001e8510f" title="NCCN临床实践指南:前列腺癌(2019.V4)" target=_blank>NCCN临床实践指南:前列腺癌(2019.V4)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6fa6b1c001e78a0e" title="中国前列腺癌患者基因检测专家共识(2019年版)" target=_blank>中国前列腺癌患者基因检测专家共识(2019年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=ae3f81c001e730f2" title="2019 CUA/CUOG指南:去势抵抗性前列腺癌的管理(草稿)" target=_blank>2019 CUA/CUOG指南:去势抵抗性前列腺癌的管理(草稿)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" target=_blank>有关前列腺癌更多指南</a></ul>, tagList=[TagDto(tagId=37065, tagName=局限性前列腺癌), TagDto(tagId=6811, tagName=放射治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4822, appHits=159, showAppHits=52, pcHits=3494, showPcHits=1840, likes=67, shares=0, comments=2, approvalStatus=1, publishedTime=Mon Nov 04 22:42:04 CST 2019, publishedTimeString=2019-10-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 04 22:42:04 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 08:19:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ESTRO-ACROP共识指南:影像学指导局限性前列腺癌的放射治疗)])
2019 ESTRO-ACROP共识指南:影像学指导局限性前列腺癌的放射治疗
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=892843, encodeId=568c8928432f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:10 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374912, encodeId=66283e49125d, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Nov 07 22:34:11 CST 2019, time=2019-11-07, status=1, ipAttribution=)]
    2020-10-18 answer.col

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=892843, encodeId=568c8928432f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:10 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374912, encodeId=66283e49125d, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Nov 07 22:34:11 CST 2019, time=2019-11-07, status=1, ipAttribution=)]
    2019-11-07 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0